Metrics as of 10/13/2026, 06:55 PM (Berlin time), refresh in progress.
HeartBeam Stock
HeartBeam, Inc.
Company data
- Sector
- Healthcare
- Industry
- Medical - Specialties
- Country
- United States
- CEO
- Branislav Vajdic
- Employees
- 16
- Market cap
- $22 M
- IPO
- 16/11/2021
HeartBeam, Inc. is a development stage company, which engages in cardiovascular diagnostic technology. Its electrocardiogram (ECG) collection device provides physicians with cardiac diagnostic information for a patient that is outside of a medical institution. The device sends ECG signals to the patient's smartphone…
HeartBeam stock: price history
1D
-7.7%
1W
-32.9%
1M
-3.5%
6M
-67.3%
YTD
-83.7%
1Y
-77.5%
2Y
-81.8%
5Y
–
10Y
–
Next earnings date
Next earnings date
12/11/2026 (in 26 days)
Volatility around earnings
~15% weaker price swings than usual
Ask the agents about HeartBeam
Analyst assessment of HeartBeam
PRICE TARGET LOW
US$2.00
CONSENSUS
US$2.00
MEDIAN
US$2.00
PRICE TARGET HIGH
US$2.00
0
STRONG BUY
8
BUY
5
HOLD
0
SELL
0
STRONG SELL
13
TOTAL · Buy
As of: 22/09/2026
HeartBeam stock metrics
P/E
-0.75
P/B
2.53
EV/EBITDA
-0.64
RETURN ON EQUITY
-61.6%
NET MARGIN
0.0%
DEBT/EQUITY
0
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
85.5%
FLOAT SHARES
47,452,238
AVG. DAILY VOLUME (30D)
14,878,759
Insider transactions (SEC)
Vajdic Branislav
Vajdic Branislav
Cruickshank Tim
Persen Kenneth Harry
Institutional holders
Comparable stocks
Frequently asked questions about HeartBeam stock
What does HeartBeam do?
HeartBeam, Inc. is a company in the Healthcare sector, Medical - Specialties industry, headquartered in United States.
The CEO is Branislav Vajdic, the company employs around 16 people.
The IPO was on 16/11/2021; the stock trades on NASDAQ under the ticker BEAT.
What do analysts say about HeartBeam stock?
13 analysts rate the stock, the consensus is Buy (as of 22/09/2026).
The average price target is US$2.00, ranging from US$2.00 to US$2.00, with a median of US$2.00.
This is an external assessment, not a statement by Market Jury.
When does HeartBeam report next?
The next earnings date is 12/11/2026.
Around past earnings, price swings were roughly -15% stronger than usual.
Does HeartBeam pay a dividend?
No, HeartBeam currently does not pay a dividend.
Which stocks are comparable to HeartBeam?
Comparable stocks include STERIS, QuidelOrtho, Mesa Laboratories, 908 Devices, Trinity Biotech, Eli Lilly and Company, Johnson & Johnson and AbbVie.
How can I get HeartBeam stock analyzed?
Clicking "Analyze stock" lets five strategies assess HeartBeam against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.